HIV testing in people with presumptive tuberculosis: Time for implementation

The Lancet Respiratory Medicine

Volumn 1, Issue 1, 2013, Pages 7-9

  Kumar, Ajay MV ^a   Gupta, Devesh ^b   Gupta, Radhe S ^b   Satyanarayana, Srinath ^a   Wilson, Nevin ^a   Zachariah, Rony ^c   Lawn, Stephen D ^d,e   Harries, Anthony D ^a,e  

^a INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

^b GOVERNMENT OF INDIA   (India)

^c MÉDECINS SANS FRONTIÈRES   (Switzerland)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; COTRIMOXAZOLE; RIFAMPICIN;

ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ANTIVIRAL THERAPY; CD4 LYMPHOCYTE COUNT; DISEASE ASSOCIATION; DRUG RESISTANT TUBERCULOSIS; EPIDEMIC; EPIDEMIOLOGICAL DATA; FOLLOW UP; HEALTH CARE PLANNING; HEALTH CARE POLICY; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION CONTROL; LETTER; LONG TERM CARE; LUNG TUBERCULOSIS; MORBIDITY; MORTALITY; NUCLEIC ACID AMPLIFICATION; OPPORTUNISTIC INFECTION; PATIENT CARE; PATIENT COUNSELING; PATIENT MONITORING; PRIORITY JOURNAL; SPUTUM SMEAR; TUBERCULOSIS RAPID TEST; WORLD HEALTH ORGANIZATION; ZIMBABWE; COMPLICATION; HIV INFECTIONS; SERODIAGNOSIS; STANDARDS; TUBERCULOSIS, PULMONARY;

AIDS SERODIAGNOSIS; HIV INFECTIONS; HUMANS; TUBERCULOSIS, PULMONARY;

EID: 84880044266     PISSN: 22132600     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2213-2600(12)70050-4     Document Type: Letter

References (10)

1. Global HIV/AIDS response. Epidemic update and health sector progress towards universal access. Progress Report 2011 2011, WHO, UNAIDSUNAIDS, UnicefUnicef, World Health Organization, Geneva.
2. Global tuberculosis control 2011. World Health Organization document WHO/HTM/TB/2011.16:1-246 2011, WHO, World Health Organization, Geneva.
3. WHO policy on collaborative TB/HIV activities. Guidelines for national programmes and other stakeholders. World Health Organization document WHO/HTM/TB/2012.1:1-34 2012, WHO, World Health Organization, Geneva.
4. Macpherson P, Dimairo M, Bandason T, et al. Risk factors for mortality in smear-negative tuberculosis suspects: a cohort study in Harare, Zimbabwe. Int J Tuberc Lung Dis 2011, 15:1390-1396.
5. Srikantiah P, Lin R, Walusimbi M, et al. Elevated HIV seroprevalence and risk behaviours among Ugandan TB suspects: implications for HIV testing and prevention. Int J Tuberc Lung Dis 2007, 11:168-174.
6. Achanta S, Kumar AM, Nagaraja SB, et al. Feasibility and effectiveness of provider initiated HIV testing and counseling of TB suspects in Vizianagaram district, south India. PLoS One 2012, 7:e41378.
7. Naik B, Kumar AMV, Lal K, et al. HIV prevalence among persons suspected of tuberculosis: policy implications for India. J Acquir Immune Defic Syndr 2012, 59:e72-e76.
8. Suthar AB, Lawn SD, del Amo J, et al. Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis. PLoS Med 2012, 9:e1001270.
9. Harries AD, Lawn SD, Getahun H, Zachariah R, Havlir DV HIV and tuberculosis- science and implementation to turn the tide and reduce deaths. J Int AIDS Soc 2012, 15:17396.
10. Harries AD Paying attention to tuberculosis suspects whose sputum smears are negative. Int J Tuberc Lung Dis 2011, 15:427-428.